(Q64126934)
Statements
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment (English)
Gordon R Bernard
Richard Beale
Christopher Doig
Christian Putensen
Jean-Francois Dhainaut
Antonio Artigas
Roberto Fumagalli
William Macias
Theressa Wright
Kar Wong
Mary Ann Turlo
Jonathan Janes